COMPOSITIONS COMPRISING A T CELL REDIRECTION THERAPEUTIC AND A VLA-4 ADHESION PATHWAY INHIBITOR | Patent Publication Number 20210363252

US 20210363252 A1
Patent Number-
Application Number17322973
Filled DateMay 18, 2021
Priority DateMay 19, 2020
Publication DateNov 25, 2021
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsFrancois Gaudet
Priyanka Nair-Gupta
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.